Air Liquide Buys Business Operations of Lion Copolymer Geismar Services

Air Liquide Large Industries U.S. LP announces the acquisition of the assets and business activities of Lion Copolymer Geismar Services (LCGS), an industrial utilities provider based in Louisiana’s Geismar basin, near the city of Baton Rouge.

The newly acquired facilities are a major utilities provider in the area and supply steam, treated and demineralized water, and other critical products to nearby industrial customers in the Geismar basin, a number of which are already being supplied industrial gases by Air Liquide.

The purchase of LCGS’ business operations and assets complements Air Liquide’s already strong presence in the Geismar basin, which is anchored by two large air separation units producing oxygen and nitrogen for supply via the company’s expansive Mississippi River Pipeline System, as well as a cogeneration unit which produces electricity and steam.

Michael J. Graff, President and CEO of American Air Liquide Holdings, Inc., Vice-President Americas and a member of Air Liquide’s Executive Committee, commented: “The purchase of LCGS’ business activities further demonstrates Air Liquide’s growth strategy in existing and essential marketplaces. This investment will generate immediate revenue and expands our product offer and position in the region by integrating new and existing capabilities to meet the needs of customers. We welcome our new employees, and are pleased to be adding to our already substantial investment in the Geismar basin and to continue to contribute to growth in the Gulf Coast region.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.